Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00128154 · ClinicalTrials.gov registry record · NA
Chromium Picolinate for the Treatment of Metabolic Syndrome
A NA study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00128154 is a NA study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 60 participants.
The verdict
NCT00128154, a NA study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether chromium supplements can reduce symptoms of metabolic syndrome, a collection of symptoms that increase one's risk for developing heart disease, stroke, and diabetes.
Interventions
- DRUG Chromium picolinate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2004-01 |
| Est. Completion | 2005-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00128154
The ClinicalTrials.gov registry entry for NCT00128154 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chromium picolinate is the first listed.
NCT00128154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00128154 about?
NCT00128154 is a clinical study titled "Chromium Picolinate for the Treatment of Metabolic Syndrome". The purpose of this study is to determine whether chromium supplements can reduce symptoms of metabolic syndrome, a collection of symptoms that increase one's risk for developing heart disease, stroke, and diabetes.
What is the current status of trial NCT00128154?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2004-01. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00128154?
The interventions under investigation include: Chromium picolinate (DRUG).
Who is sponsoring clinical trial NCT00128154?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.